EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Tumor volume as a prognostic factor on the median survival in locally advanced oral cancer treated with definitive chemoradiotherapy

Narumon Janmunee, Thanarpan Peerawong, Paytai Rordlamool, Jidapa Bridthikitti, Manupol Tangthongkum, Chanon Kongkamol, Siriporn Hirunpat

Indian Journal of Cancer · 2023-01 · 60 (1) · 72-79

DOI: 10.4103/ijc.ijc_86_20 ↗
AbstractBibliografische Angaben

Abstract

Background: Surgery has been the mainstay treatment for oral cancer. Patients who do not receive surgery are generally treated with concurrent chemoradiotherapy (CCRT). Many factors play a role in patients’ survival; tumor volume might be one of those factors. This study aims to determine the effect of the pre-treatment tumor volume on the survival of oral cancer. Methods: Retrospective study of patients with histological confirmed squamous cell carcinoma, stage III–IV oral cancer, who received definitive CCRT. Tumor volume from pre-treatment computed tomography (CT) scans were reviewed and analyzed. The optimal cut-off tumor volume was evaluated by receiver operating characteristic (ROC) curve analysis. Results: Among 67 patients, half of the primary tumor sites were oral tongue. The median total tumor volume (TTV) was 73.25 cm 3 , while the median survival was 12.5 months (95% confidence interval: 10.9-20.3). The optimal cut-off TTV ≥52.9 cm 3 ( P < 0.0001). The median survival of the patients, who had tumor volume

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →